References
Boyer JL. Nuclear receptor ligands: rational and effective therapy for cholestatic liver disease. Gastroenterology 2005;129:735–740
Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006;43:S32–S44
Krishnamurthy GT, Krishnamurthy S. Nuclear hepatology: a textbook of hepatobiliary diseases. New York: Springer;2000
Klingensmith WC III, Whitney WP, Spitzer VM, Klintmalm GB, Koep LM, Kuni CC. Effect of complete biliary-tract obstruction on serial hepatobiliary imaging in an experimental model: concise communication. J Nucl Med 1981;22:866–868
Krishnamurthy GT, Krishnamurthy S. Pathophysiology of acute critical obstruction of the common bile duct: role of quantitative cholescintigraphy and ultrasound in early detection and patient management. Indian J Nucl Med 2003;18:66–72
Lieberman DA, Brown PH, Krishnamurthy GT. Improved scintigraphic assessment of severe cholestasis with the hepatic extraction fraction. Dig Dis Sci 1990;35:1385–1390
Vetelainen RL, Bennick RJ, deBruin K, vanVliet AK, vanGulic TM. Hepatobiliary function assessed by Tc-99m mebrofenin scintigraphy correlates with the severity of steatosis in a rat model. Eur J Nucl Med Mol Imaging 2006; DOI 10.1007/s00259-006-0125-3
Day CP. From fat to inflammation. Gastroenterology 2006;130:207–210
Lemasters JJ. Dying a thousand deaths: redundant pathway from different organelles to apoptosis and necrosis. Gastroenterology 2005;129:351–360
Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, Kullak-Ublick GA, et al. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 2003;38:345–354
Hartman G, Cheung AK, Piquette-Miller M. Inflammatory cytokines, but not bile acids, regulate the expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther 2002;303:273–281
Joseph B, Bhargava KK, Tronco G, Kumaran V, Palestro CJ, Gupta S. Regulation of hepatobiliary transport activity and non-invasive identification of cytokine-dependent liver inflammation. J Nucl Med 2005;46:146–152
Malhi H, Bhargava KK, Afriyie MO, Volenberg I, Schilsky ML, Palestro CJ, et al. Technetium-99m mebrofenin scintigraphy for evaluating liver disease in a rat model of Wilson’s disease. J Nucl Med 2002;43:246–252
Gehring S, Dickson EM, San Martin ME, van Rooijen N, Papa EF, Harty MW, et al. Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology 2006;130:810–822
Author information
Authors and Affiliations
Corresponding author
Additional information
This editorial commentary refers to the article http://dx.doi.org/10.1007/s00259-006-0125-3.
Appendix
Appendix
- ALP:
-
Alkaline phosphatase
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- BSEP:
-
Bile salt export protein
- FFA:
-
Free fatty acids
- HIDA:
-
Hepatic iminodiacetic acid
- IL:
-
Interleukin
- MDR:
-
Multidrug resistance protein
- MPT:
-
Mitochondrial permeability transition pores
- MRP:
-
Multidrug resistance-associated protein
- NF-κB:
-
Nuclear factor-kappa B
- NTCP:
-
Sodium taurocholate cotransport protein
- OATP:
-
Organic anion transport protein
- OC:
-
Organic cation pump
- RER:
-
Rough endoplasmic reticulum
- SER:
-
Smooth endoplasmic reticulum
- TGF-β:
-
Transforming growth factor-β
- TNF-α:
-
Tumor necrosis factor-α
Rights and permissions
About this article
Cite this article
Krishnamurthy, G.T., Krishnamurthy, S. Cholescintigraphic measurement of liver function: how is it different from other methods?. Eur J Nucl Med Mol Imaging 33, 1103–1106 (2006). https://doi.org/10.1007/s00259-006-0182-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-006-0182-7